Sickle-cell disease stroke throughout life: A retrospective study in an adult referral center

American Journal of Hematology

Volumn 89, Issue 3, 2014, Pages 267-272

  Gueguen, Antoine ^a,b   Mahevas, Matthieu ^b   Nzouakou, Ruben ^b   Hosseini, Hassan ^b   Habibi, Anoosha ^b   Bachir, Dora ^b   Brugière, Pierre ^b   Lionnet, François ^c   Ribeil, Jean Antoine ^d   Godeau, Bertrand ^b   Girot, Robert ^c   Ibrahima, Vahid ^b   Calvet, David ^e   Galactéros, Frédéric ^b,f   Bartolucci, Pablo ^b,f  

^a Service de neurologie   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c HÔPITAL TENON   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e CENTRE HOSPITALIER SAINTE ANNE   (France)

^f INSERM U955   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CRANIAL SINUS; FATALITY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE; YOUNG ADULT;

ADULT; AGE OF ONSET; AGED; ANEMIA, SICKLE CELL; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RECURRENCE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 84896882046     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23625     Document Type: Article

References (40)

1. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639-1644.
2. Powars DR, Chan LS, Hiti A, et al. Outcome of sickle cell anemia: A 4-decade observational study of 1056 patients. Medicine (Baltimore). 2005;84:363-376.
3. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-294.
4. Enninful-Eghan H, Moore RH, Ichord R, et al. Transcanial Doppler screening and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease. J Pediatr 2010;157:479-484.
5. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
6. Fullerton HJ, Adams RJ, Zhao S, Johnston SC. Declining stroke rates in Californian children with sickle cell disease. Blood 2004;104:336-339.
7. Strouse JJ, Jordan LC, Lanzkron S, JF Casella. The excess burden of stroke in hospitalized adults with sickle cell disease. Am J Hematol 2009;84:548-552.
8. Gyang E, Yeom K, Hoppe C, et al. Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease. Am J Hematol 2011;86:104-106.
9. Hulbert ML, McKinstry RC, Lacey JL, et al. Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood 2011;117:772-779.
10. The global burden of cerebrovascular disease. [cited 2006 Jun 21]. Available at: http://www.who.int/healthinfo/statistics/bod_cerebrovasculardiseasestroke.pdf.
11. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('Moyamoya' disease). Clin Neurol Neurosurg 1997;99:S238-S240.
12. Haute Autorité de Santé. Guide médecin sur l'accident vasculaire cérébral (AVC) [cited 2007 Mar]. Available at: http://www.has-sante.fr/portail/jcms/r_1505260/fr/accident-vasculaire-cerebral-avc?xtmc=&xtcr=1.
13. Prevention of cardiovascular disease: Guidelines for assessment and management of cardiovascular risk. [cited 2007 Aug 24]. Available at: http://www.who.int/cardiovascular_diseases/guidelines/Prevention_of_Cardiovascular_Disease/en/index.html.
14. Hankins JS, Fortner GL, McCarville MB, et al. The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia. Br J Haematol 2008;142:94-99.
15. Rothman SM, Fulling KH, Nelson JS. Sickle cell anemia and central nervous system infarction: A neuropathological study. Ann Neurol 1986;20:684-690.
16. Gerald B, Sebes JI, Langston JW. Cerebral infarction secondary to sickle cell disease: Arteriographic findings. AJR Am J Roentgenol 1980;134:1209-1212.
17. Stockman JA, Nigro MA, Mishkin MM, Oski FA. Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med 1972;287:846-849.
18. Adams RJ, Nichols FT, McKie V, et al. Cerebral infarction in sickle cell anemia: Mechanism based on CT and MRI. Neurology 1988;38:1012-1017.
19. Moser FG, Miller ST, Bello JA, et al. The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol 1996;17:965-972.
20. Gavins F, Yilmaz G, Granger DN. The evolving paradigm for blood cell-endothelial cell interactions in the cerebral microcirculation. Microcirculation 2007;14:667-681.
21. Prengler M, Pavlakis SG, Boyd S, et al. Sickle cell disease: Ischemia and seizures. Ann Neurol 2005;58:290-302.
22. Powars DR, Conti PS, Wong WY, et al. Cerebral vasculopathy in sickle cell anemia: Diagnostic contribution of positron emission tomography. Blood 1999;93:71-79.
23. Powars D, Wilson B, Imbus C, et al. The natural history of stroke in sickle cell disease. Am J Med. 1978;65:461-471.
24. Godeau B. [Emergencies in adults with sickle cell disease]. Bull Acad Natl Med 2004;188:507-517.
25. Saeki N, Nakazaki S, Kubota M, et al. Hemorrhagic type Moyamoya disease. Clin Neurol Neurosurg 1997;99:S196-S201.
26. Kopitnik TA, Samson DS. Management of subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1993;56:947-959.
27. Oyesiku NM, Barrow DL, Eckman JR, et al. Intracranial aneurysms in sickle-cell anemia: Clinical features and pathogenesis. J Neurosurg 1991;75:356-363.
28. Preul MC, Cendes F, Just N, Mohr G. Intracranial aneurysms and sickle cell anemia: Multiplicity and propensity for the vertebrobasilar territory. Neurosurgery 1998;42:971-978.
29. Batjer HH, Adamson TE, Bowman GW. Sickle cell disease and aneurysmal subarachnoid hemorrhage. Surg Neurol 1991;36:145-149.
30. Pegelow CH, Adams RJ, McKie V, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995;126:896-899.
31. Scothorn DJ, Price C, Schwartz D, et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002;140:348-354.
32. Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005;353:2769-2778.
33. Ware RE, Schultz WH, Yovetich N, et al. Stroke with transfusions changing to hydroxyurea (SWITCH): A phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload. Pediatr Blood Cancer 2011;57:1011-1017.
34. Lefèvre N, Dufour D, Gulbis B, et al. Use of hydroxyurea in prevention of stroke in children with sickle cell disease. Blood 2008;111:963-964.
35. Ali SB, Moosang M, King L, et al. Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke. Am J Hematol 2011;86:846-850.
36. Zimmerman SA, Schultz WH, Burgett S, et al. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. Blood 2007;110:1043-1047.
37. Bernaudin F, Verlhac S, Arnaud C, et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood 2011;117:1130-1140.
38. Bernaudin F, Verlhac S, Coïc L, et al. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Pediatr Radiol 2005;35:242-248.
39. Phillips G Jr, Coffey B, Tran-Son-Tay R, et al. Relationship of clinical severity to packed cell rheology in sickle cell anemia. Blood 1991;78:2735-2739.
40. Jan K, Usami S, Smith JA. Effects of transfusion on rheological properties of blood in sickle cell anemia. Transfusion 1982;22(17-20).